Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries - Top-Institutions - MDSpire

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries

  • By

  • Sabina Chiaretti

  • Sabine Blum

  • Thibaut Leguay

  • Marie Balsat

  • Cyril Salek

  • Nicola Fracchiolla

  • Alexandros Spyridonidis

  • Anita Rijneveld

  • Cristina Papayannidis

  • Albertina Nunes

  • Anne Christine Wilke

  • Sigrid Machherndl-Spandl

  • Ulla Wartiovaara-Kautto

  • Jessica Choudhry

  • Ravikanth Maraboina

  • Gerhard Zugmaier

  • Noemi Mergen

  • Andreas Ochs

  • Alessandro Rambaldi

  • May 2, 2026

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Children’s Oncology Group
    Children’s Oncology Group

    Washington, DC

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Seattle Children’s Hospital
    Seattle Children’s Hospital

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    ECOG-ACRIN Cancer Research Group
    ECOG-ACRIN Cancer Research Group

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries

  • by Sabina Chiaretti, Sabine Blum, Thibaut Leguay, Marie Balsat, Cyril Salek, Nicola Fracchiolla, Alexandros Spyridonidis, Anita Rijneveld, Cristina Papayannidis, Albertina Nunes, Anne Christine Wilke, Sigrid Machherndl-Spandl, Ulla Wartiovaara-Kautto, Jessica Choudhry, Ravikanth Maraboina, Gerhard Zugmaier, Noemi Mergen, Andreas Ochs, Alessandro Rambaldi

  • May 2, 2026

Related Content

The AACR 2026 Roundup: Why Quantitative Precision Matters

From detection to supporting decisions, Marwan A. Alsarraj reports on precision diagnostics updates from the major cancer conference

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab